Media ReleasesAirXpanders Inc

View All AirXpanders Inc News

AirXpanders Announces 5th Prospective Trial Confirms Physician and Patient Satisfaction, Ease of Use and Convenience with AeroForm® Tissue Expander System

- Data on delivery of radiation with AeroForm in vivo with no increased toxicity also presented

PALO ALTO, CA, United States, October 9, 2017 — AirXpanders, Inc. (ASX:AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that new data on the use of its AeroForm® Tissue Expander System was presented during the 86th Plastic Surgery: The Meeting, the annual scientific meeting of the American Society of Plastic Surgery (ASPS), October 6-10, in Orlando, FL.

For further information please download PDF attached:
Download this document